{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:33:13Z","timestamp":1766136793789},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jim.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T14:48:04Z","timestamp":1484578084000},"page":"35-41","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx\u2122 C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue"],"prefix":"10.1016","volume":"442","author":[{"given":"Eric P.","family":"Dixon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine M.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G.","family":"Simkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George H.","family":"Brough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorian T.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clark M.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice","family":"Hessling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas P.","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2017.01.002_bb0005","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":"Worldwide burden of cervical cancer in 2008","volume":"22","author":"Arbyn","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jim.2017.01.002_bb3000","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/PAS.0b013e31815bbb69","article-title":"BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix","volume":"32","author":"Badr","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jim.2017.01.002_bb0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cncr.23496","article-title":"Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology","volume":"114","author":"Beccati","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1155\/2012\/289315","article-title":"Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs","volume":"2012","author":"Brown","year":"2012","journal-title":"J. Oncol."},{"key":"10.1016\/j.jim.2017.01.002_bb0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjc.6603653","article-title":"High-risk HPV type-specific clearance rates in cervical screening","volume":"96","author":"Bulkmans","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb2000","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cncr.21713","article-title":"Role of P16 (INK4A) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colpolscopy after abnormal cytology","volume":"108","author":"Carozzi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0025","first-page":"1927","article-title":"Identification of cervical cancer markers by cDNA and tissue microarrays","volume":"15","author":"Chen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2017.01.002_bb0030","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/jcp.2004.022863","article-title":"Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study","volume":"58","author":"Cuschieri","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jim.2017.01.002_bb0035","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0040","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/1055-9965.EPI-10-0818","article-title":"BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening","volume":"20","author":"Depuydt","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jim.2017.01.002_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/LGT.0b013e3181f0b4b7","article-title":"ProExC triage of atypical glandular cells on liquid-based cervical cytology specimens","volume":"15","author":"Fletcher","year":"2011","journal-title":"J Low Genit. Tract Dis."},{"key":"10.1016\/j.jim.2017.01.002_bb0050","first-page":"2121","article-title":"Minichromosome maintenance proteins as biological markers of dysplasia and malignancy","volume":"5","author":"Freeman","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jim.2017.01.002_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","article-title":"Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay","volume":"77","author":"Friguet","year":"1985","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2017.01.002_bb0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/cncr.23951","article-title":"Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study","volume":"114","author":"Halloush","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2011.04.008","article-title":"The selection and characterization of antibodies to minichromosome maintenance proteins that highlight cervical dysplasia","volume":"370","author":"Henderson","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2017.01.002_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jim.2017.01.002_bb0075","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/cncr.22288","article-title":"Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C)","volume":"25","author":"Kelly","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/hyb.1997.16.381","article-title":"Rapid development of affinity matured monoclonal antibodies using RIMMS","volume":"16","author":"Kilpatrick","year":"1997","journal-title":"Hybridoma"},{"key":"10.1016\/j.jim.2017.01.002_bb9000","first-page":"31","article-title":"Epitope mapping using the in vitro Roche Rapid Translation System RTS 100","volume":"4","author":"King","year":"2006","journal-title":"Biochemica"},{"key":"10.1016\/j.jim.2017.01.002_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.jim.2017.01.002_bb0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/PAS.0b013e3181e3291e","article-title":"A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas","volume":"34","author":"Kong","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"Suppl:17","key":"10.1016\/j.jim.2017.01.002_bb0095","article-title":"Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease","author":"Malinowski","year":"2005","journal-title":"BioTechniques"},{"key":"10.1016\/j.jim.2017.01.002_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1586\/14737159.7.2.117","article-title":"Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection","volume":"7","author":"Malinowski","year":"2007","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"16","key":"10.1016\/j.jim.2017.01.002_bb0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"2000","author":"Nanda","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jim.2017.01.002_bb0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"21","author":"Naucler","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jim.2017.01.002_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/PGP.0b013e31820a79b0","article-title":"Usefulness of p16Ink4a, ProEx C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri","volume":"30","author":"Negri","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.jim.2017.01.002_bb0120","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/1097-0142(19951115)76:10+<1902::AID-CNCR2820761306>3.0.CO;2-0","article-title":"Molecular biology of cervical cancer and its precursors","volume":"15","author":"Park","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.mpdhp.2010.06.012","article-title":"Molecular markers of early cervical neoplasia","volume":"16","author":"Pinto","year":"2010","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.jim.2017.01.002_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000335065","article-title":"Immunomarkers in gynecologic cytology: the search for the ideal biomolecular papanicolaou test","volume":"56","author":"Pinto","year":"2012","journal-title":"Acta Cytol."},{"key":"10.1016\/j.jim.2017.01.002_bb0135","first-page":"27","article-title":"Activity level and process indicators of organised programmes for cervical cancer screening in Italy","volume":"30","author":"Ronco","year":"2006","journal-title":"Epidemiol. Prev."},{"key":"10.1016\/j.jim.2017.01.002_bb0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/PGP.0b013e3181ae81a0","article-title":"Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens","volume":"29","author":"Sanati","year":"2010","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.jim.2017.01.002_bb0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.virol.2004.09.045","article-title":"Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy","volume":"20","author":"Santin","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jim.2017.01.002_bb0150","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5858\/2003-127-946-FTDFTA","article-title":"Findings to date from the ASCUS-LSIL Triage Study (ALTS)","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jim.2017.01.002_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1097-0142(19970425)81:2<89::AID-CNCR2>3.0.CO;2-9","article-title":"Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing","volume":"25","author":"Sherman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0160","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.humpath.2007.01.025","article-title":"Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a\/ProEX C in cervical squamous intraepithelial lesions","volume":"38","author":"Shi","year":"2007","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jim.2017.01.002_bb0165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cncr.22171","article-title":"Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology","volume":"25","author":"Shroyer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jim.2017.01.002_bb0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.5858\/2003-127-935-HPBACN","article-title":"Human papillomavirus biology and cervical neoplasia: implications for diagnostic criteria and testing","volume":"127","author":"Stoler","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jim.2017.01.002_bb0175","doi-asserted-by":"crossref","first-page":"918","DOI":"10.5858\/2008-132-918-LCEOAN","article-title":"Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens","volume":"132","author":"Tambouret","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jim.2017.01.002_bb0180","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2008.12.005","article-title":"p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia","volume":"40","author":"Walts","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jim.2017.01.002_bb0185","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/1055-9965.EPI-05-0151","article-title":"Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods","volume":"14","author":"Wang","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jim.2017.01.002_bb0190","doi-asserted-by":"crossref","first-page":"14932","DOI":"10.1073\/pnas.95.25.14932","article-title":"Improved cervical smear assessment using antibodies against proteins that regulate DNA replication","volume":"95","author":"Williams","year":"1998","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916303015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916303015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T21:08:55Z","timestamp":1658437735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175916303015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":41,"alternative-id":["S0022175916303015"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2017.01.002","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx\u2122 C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}